Diagnostic and therapeutic challenges.
Jennifer
J
Arnold
Susan
S
Kelly
Alex
A
Hunyor
David
D
Wilson
Murat
M
Karacorlu
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D003131:Combined Modality Therapy; D019773:Epiretinal Membrane / Q000175:diagnosis* / Q000628:therapy; D005260:Female; D005451:Fluorescein Angiography; D018325:Hemangioblastoma / Q000473:pathology* / Q000628:therapy; D006801:Humans; D017075:Laser Coagulation; D008269:Macular Edema / Q000175:diagnosis* / Q000628:therapy; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000628:therapy; D011244:Pregnadienediols / Q000627:therapeutic use; D019572:Retinal Neoplasms / Q000473:pathology* / Q000628:therapy; D015861:Retinal Neovascularization / Q000175:diagnosis / Q000628:therapy; D014786:Vision Disorders / Q000534:rehabilitation*; D014792:Visual Acuity; D006623:von Hippel-Lindau Disease / Q000235:genetics*
D020533:Angiogenesis Inhibitors; D011244:Pregnadienediols; C418047:anecortave acetate